A review of antioxidant and pharmacological properties of phenolic compounds in Acacia confusa

Journal of Traditional and Complementary Medicine

Volumn 8, Issue 4, 2018, Pages 443-450

  Lin, Huan You ^a   Chang, Tzu Cheng ^a   Chang, Shang Tzen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Acacia confusa; Antioxidant; Flavonoids; Functional food; Leguminosae; Pharmacological properties

Indexed keywords

EID: 85049086789     PISSN: None     EISSN: 22254110     Source Type: Journal    
DOI: 10.1016/j.jtcme.2018.05.002     Document Type: Review

References (86)

1. Kan, W.S., Leguminosae. Kan, W.S., (eds.) Manual of Medicinal Plants in Taiwan, vol. 2, 1978, National Research Institute of Chinese Medicine, Taipei, 239–240.
2. Huang, T.C., Ohashi, H., Leguminosae., second ed. Huang, T.C., (eds.) Flora of Taiwan, vol. 3, 1994, National Taiwan University, Taipei, 160–162.
3. Chen, Y.S.G., Wong, S.M., Whitton, B.A., Effects of landfill leachate on growth and nitrogen fixation of two Leguminous trees (Acacia confusa, Leucaena leucocephala). Water Air Soil Pollut 111 (1999), 29–40.
4. Wang, D.M., Wu, S.H., Su, C.H., Peng, J.T., Shih, Y.H., Chen, L.C., Ganoderma multipileum, the correct name for ‘G. lucidum’ in tropical Asia. Bot Stud 50 (2009), 451–458.
5. Wang, Y.C., Carbon sequestration and foliar dust retention by woody plants in the greenbelts along two major Taiwan highways. Ann Appl Biol 159 (2011), 244–251.
6. Wei, S.D., Zhou, H.C., Lin, Y.M., Liao, M.M., Chai, W.M., MALDI-TOF MS analysis of condensed tannins with potent antioxidant activity from the leaf, stem bark and root bark of Acacia confusa. Molecules 15 (2010), 4369–4381.
7. Wu, J.H., Tung, Y.T., Chien, S.C., et al. Effect of phytocompounds from the heartwood of Acacia confusa on inflammatory mediator production. J Agric Food Chem 56 (2008), 1567–1573.
8. Wu, J.H., Tung, Y.T., Wang, S.Y., Shyur, L.F., Kuo, Y.H., Chang, S.T., Phenolic antioxidants from the heartwood of Acacia confusa. J Agric Food Chem. 53 (2005), 5917–5921.
9. Tung, Y.T., Hsu, C.A., Chen, C.S., Yang, S.C., Huang, C.C., Chang, S.T., Phytochemicals from Acacia confusa heartwood extracts reduce serum uric acid levels in oxonate-induced mice: their potential use as xanthine oxidase inhibitors. J Agric Food Chem 58 (2010), 9936–9941.
10. Lin, H.Y., Chang, S.T., Antioxidant potency of phenolic phytochemicals from the root extract of Acacia confusa. Ind Crop Prod 49 (2013), 871–878.
11. Lee, T.H., Chou, C.H., Flavonoid aglycones and indole alkaloids from the roots of Acacia confusa. J Chin Chem Soc 47 (2000), 1287–1290.
12. Tung, Y.T., Wu, J.H., Huang, C.Y., Kuo, Y.H., Chang, S.T., Antioxidant activities and phytochemical characteristics of extracts from Acacia confusa bark. Bioresour Technol 100 (2009), 509–514.
13. Tung, Y.T., Wu, J.H., Kuo, Y.H., Chang, S.T., Antioxidant activities of natural phenolic compounds from Acacia confusa bark. Bioresour Technol 98 (2007), 1120–1123.
14. Hsieh, C.Y., Chang, S.T., Antioxidant activities and xanthine oxidase inhibitory effects of phenolic phytochemicals from Acacia confusa twigs and branches. J Agric Food Chem 58 (2010), 1578–1583.
15. Dewick, P.M., Medicinal Natural Products: a Biosynthetic Approach. 3th ed, 2009, John Wiley & Sons Ltd, New York.
16. Hassanpour, S., Sadaghian, M., Maheri-Sis, N., Eshratkhah, B., Chaichi-Semsari, M., Effect of condensed tannin on controlling faecal protein excretion in nematode-infected sheep: in vivo study. J Am Sci. 7 (2011), 896–900.
17. Zucker, W.V., Tannins: does structure determine function? An ecological perspective. Am Nat 121 (1983), 335–365.
18. Hagerman, A.E., Buttler, L.G., The specificity of proanthocyanidin-protein interactions. J Biol Chem 256 (1981), 4494–4497.
19. Hassanpour, S., Maheri-Sis, N., Eshratkhah, B., Mehmandar, F.B., Plants and secondary metabolites (tannins): a review. Int J For Soil Eros (IJFSE) 1 (2011), 47–53.
20. Haslam, E., Plant Polyphenols Vegetable Tannins Revisited. 1989, Cambridge University Press, Cambridge.
21. Tung, Y.T., Wu, J.H., Hsieh, C.Y., Chen, P.S., Chang, S.T., Free radical-scavenging phytochemicals of hot water extracts of Acacia confusa leaves detected by an on-line screening method. Food Chem 115 (2009), 1019–1024.
22. Lin, S.S., Shiau, I.L., Chang, S.T., Antioxidant activity of constituents from the methanolic extract of Acacia confusa leaves. Taiwan J For Sci 24 (2009), 61–68.
23. Lee, T.H., Qiu, F., Waller, G.R., Chou, C.H., Three new flavonol galloylglycosides from leaves of Acacia confusa. J Nat Prod 63 (2000), 710–712.
24. Tung, Y.T., Chang, W.C., Chen, P.S., Chang, T.C., Chang, S.T., Ultrasound-assisted extraction of phenolic antioxidants from Acacia confusa flowers and buds. J Separ Sci 34 (2011), 844–851.
25. Wu, J.H., Huang, C.Y., Tung, Y.T., Chang, S.T., Online RP-HPLC-DPPH screening method for detection of radical-scavenging phytochemicals from flowers of Acacia confusa. J Agric Food Chem 56 (2008), 328–332.
26. Buchanan, M.S., Carroll, A.R., Pass, D., Quinn, R.J., NMR spectral assignments of a new chlorotryptamine alkaloid and its analogues from Acacia confusa. Magn Reson Chem 45 (2007), 359–361.
27. Chang, S.T., Wu, J.H., Wang, S.Y., Kang, P.L., Yang, N.S., Shyur, L.F., Antioxidant activity of extracts from Acacia confusa bark and heartwood. J Agric Food Chem 49 (2001), 3420–3424.
28. Ho, S.T., Tung, Y.T., Chen, Y.L., Zhao, Y.Y., Chung, M.J., Wu, J.H., Antioxidant activities and phytochemical study of leaf extracts from 18 indigenous tree species in Taiwan. Evid-based Complement Altern Med., 2012, 215959, 10.1155/2012/215959.
29. Chang, C.H., Li, W.H., Shi, Y.C., Huang, C.W., Chang, S.T., Liao, V.H.C., Caenorhabditis elegans as model organisms to study the antioxidant potency of Acacia confusa twig extract. Quart J Chin Forest. 45 (2012), 503–514.
30. Adibhatla, R.M., Hatcher, J.F., Altered lipid metabolism in brain injury and disorders. Subcell Biochem 49 (2008), 241–268.
31. Florence, T.M., The role of free radicals in disease. Aust N Z J Ophthalmol 23 (1995), 3–7.
32. Tung, Y.T., Wu, J.H., Huang, C.C., et al. Protective effect of Acacia confusa bark extract and its active compound gallic acid against carbon tetrachloride-induced chronic liver injury in rats. Food Chem Toxicol 47 (2009), 1385–1392.
33. http://www.who.int/mediacentre/news/releases/2016/world-hepatitis-day/en/. Accessed 20 July 2016.
34. Thilakchand, K.R., Mathai, R.T., Simon, P., Ravi, R.T., Baliga-Rao, M.P., Baliga, M.S., Hepatoprotective properties of the Indian gooseberry (Emblica officinalis Gaertn): a review. Food Funct. 4 (2013), 1431–1441.
35. Adewusi, E.A., Afolayan, A.J., A review of natural products with hepatoprotective activity. J Med Plants Res 4 (2010), 1318–1334.
36. Chattopadhyay, R.R., Possible mechanism of hepatoprotective activity of Azadirachta indica leaf extract: part II. J Ethnopharmacol 89 (2003), 217–219.
37. Jain, S.K., Rajvaidy, S., Desai, P., Singh, G.K., Nagori, B.P., Herbal extract as hepatoprotective-a review. J Pharmacogn Phytochem 2 (2013), 170–175.
38. Kumar, A., A review on hepatoprotective herbal drugs. Int J Res Pharm Chem 2 (2012), 96–102.
39. Kumar, S.V., Sanjeev, T., Ajay, S., Kumar, S.P., Anil, S., A review on hepatoprotective activity of medicinal plants. Int J Pharm Biosci. 2 (2012), 31–38.
40. Bhawna, S., Kumar, S.U., Hepatoprotective activity of some indigenous plants. Int J Pharmtech Res. 4 (2009), 1330–1334.
41. Tung, Y.T., Chang, S.T., Inhibition of xanthine oxidase by Acacia confusa extracts and their phytochemicals. J Agric Food Chem 58 (2010), 781–786.
42. Harris, M.D., Siegel, L.B., Alloway, J.A., Gout and hyperuricemia. Am Fam Physician 59 (1999), 925–934.
43. Rasmussen, J.T., Rasmussen, M.S., Petersen, T.E., Cysteines involved in the interconversion between dehydrogenase and oxidase forms of bovine xanthine oxidoreductase. J Dairy Sci 83 (2000), 499–506.
44. Wortmann, R.L., Management of hyperuricemia. McCarthy, D.J., Koopman, W.J., (eds.) Arthritis and Allied Conditions, twelfth ed., 1993, Lea and Febiger, Philadelphia, 1807–1818.
45. Star, V.L., Hochberg, M., Prevention and management of gout. Drugs 45 (1993), 212–222.
46. Kelley, W.N., Antihyperuricemic drugs. Kelley, W.N., Harris, E.D., Ruddy, S., Sledge, C.B., (eds.) Textbook of Rheumatology, 1991, W. B. Saunders Co, Philadelphia, 862–877.
47. Lee, T.H., Liu, D.Z., Hsu, F.L., Wu, W.C., Hou, W.C., Structure-activity relationships of five myricetin galloylglycosides from leaves of Acacia confusa. Bot Stud 47 (2006), 37–43.
48. Boomsma, F., van Dijk, J., Bhaggoe, U.M., Bouhuizen, A.M.B., van den Meiracker, A.H., Variation in semicarbazide-sensitive amine oxidase activity in plasma and tissues of mammals. Comp Biochem Physiol, C 126 (2000), 69–78.
49. Mullally, M.M., Meisel, H., FitzGerald, R.J., Synthetic peptides corresponding to α-lactalbumin and β-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol Chem 377 (1996), 259–260.
50. Fotherby, M.D., Panayiotou, B., Antihypertensive therapy in the prevention of stroke: what, when, and for whom?. Drugs 58 (1999), 663–674.
51. Wang, S.Y., Yang, C.W., Liao, J.W., Zhen, W.W., Chu, F.H., Chang, S.T., Essential oil from leaves of Cinnamomum osmophloeum acts as a xanthine oxidase inhibitor and reduces the serum uric acid levels in oxonate-induced mice. Phytomedicine 15 (2008), 940–945.
52. Zhu, J.X., Wang, Y., Kong, L.D., Yang, C., Zhang, X., Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver. J Ethnopharmacol 93 (2004), 133–140.
53. de Heredia, F.P., Gomez-Martinez, S., Marcos, A., Obesity, inflammation and the immune system. Proc Nutr Soc 71 (2012), 332–338.
54. Hotamisligil, G.S., Inflammation and metabolic disorders. Nature 444 (2006), 860–867.
55. Sastre, M., Klockgether, T., Heneka, M.T., Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int J Dev Neurosci 24 (2006), 167–176.
56. Gorman, C., Park, A., Dell, K., Health: the fires within. Time 163 (2004), 38–45 23 February, USA edition.
57. Lee, J.C., Chen, W.C., Wu, S.F., et al. Anti-hepatitis C virus activity of Acacia confusa extract via suppressing cyclooxygenase-2. Antivir Res 89 (2011), 35–42.
58. Alter, M.J., Epidemiology of hepatitis C virus infection. World J Gastroenterol 13 (2007), 2436–2441.
59. Levrero, M., Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25 (2006), 3834–3847.
60. Schaefer, M., Mauss, S., Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects. Curr Drug Abuse Rev 1 (2008), 177–187.
61. Sun, B., Karin, M., NF-kappaB signaling, liver disease and hepatoprotective agents. Oncogene 27 (2008), 6228–6244.
62. Lu, L., Wei, L., Peng, G., et al. NS3 protein of hepatitis C virus regulates cyclooxygenase-2 expression through multiple signaling pathways. Virology 371 (2008), 61–70.
63. Waris, G., Siddiqui, A., Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication. J Virol 79 (2005), 9725–9734.
64. Núñez, O., Fernández-Martinez, A., Majano, P.L., et al. Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins. Gut 53 (2004), 1665–1672.
65. Penin, F., Dubuisson, J., Rey, F.A., Moradpour, D., Pawlotsky, J.M., Structural biology of hepatitis C virus. Hepatology 39 (2004), 5–19.
66. Flaherty, D.K., Immunology for Pharmacy. 2012, Mosby. Elsevier Inc, St. Louis.
67. LeBlanc, D.M., Barousse, M.M., Fidel, P.L. Jr., Role for dendritic cells in immunoregulation during experimental vaginal candidiasis. Infect Immun 74 (2006), 3213–3221.
68. Ho, S.T., Tung, Y.T., Wu, Y.J., Lin, C.C., Wu, J.H., Immune-regulatory activity of methanolic extract of Acacia confusa heartwood and melanoxetin isolated from the extract. Holzforschung 69 (2015), 645–652.
69. Dalod, M., Chelbi, R., Malissen, B., Lawrence, T., Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming. EMBO J 33 (2014), 1104–1116.
70. Trucci, V.M., Salum, F.G., Figueiredo, M.A., Cherubini, K., Interrelationship of dendritic cells, type 1 interferon system, regulatory T cells and toll-like receptors and their role in Lichen planus and Lupus erythematosus - a literature review. Arch Oral Biol 58 (2013), 1532–1540.
71. Yamada, H., Arai, T., Endo, N., et al. LPS-induced ROS generation and changes in glutathione level and their relation to the maturation of human monocyte-derived dendritic cells. Life Sci 78 (2006), 926–933.
72. Sen, P., Kemppainen, E., Orešič M., Perspectives on systems modeling of human peripheral blood mononuclear cells. Front. Mol. Biosci, 2018, 10.3389/fmolb.2017.00096.
73. Kuo, Y.C., Yang, L.M., Lin, L.C., Isolation and immunomodulatory effect of flavonoids from Syzygium samarangense. Planta Med. 70 (2004), 1237–1239.
74. Kang, J.H., Lee, J., Moon, M., Yim, M., 3’4’7-Trihydroxyflavone inhibits RANKL-induced osteoclast formation via NFATc1. Pharmazie 70 (2015), 661–667.
75. Kang, J.H., Jung, H., Yim, M., 3’,4’,7,8-Tetrahydroxyflavone inhibits RANKL-induced osteoclast formation and bone resorption. Pharmazie 72 (2017), 161–166.
76. Yavropoulou, M.P., Yovos, J.G., Osteoclastogenesis - current knowledge and future perspectives. J Musculoskelet Neuronal Interact 8 (2008), 204–216.
77. Takayanagi, H., Kim, S., Koga, T., et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3 (2002), 889–901.
78. Novack, D.V., Teitelbaum, S.L., The osteoclast: friend or foe?. Ann Rev Pathol. 3 (2008), 457–484.
79. Shulgin, A., Shulgin, A., TIHKAL: the Continuation. 1997, Transform Press, Berkeley.
80. Strassman, R.J., Qualls, C.R., Dose-response study of N,N-dimethyltryptamine humans: I. neuroendocrine autonomic, and cardiovascular effects. Arch Gen Psychiatr 51 (1994), 85–97.
81. Strassman, R.J., Qualls, C.R., Uhlenhuth, E.H., Kellner, R., Dose-response study of N,N-dimethyltryptamine in humans: II. subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatr 51 (1994), 98–108.
82. Stoff, D.M., Moja, E.A., Gillin, J.C., Wyatt, R.J., Dose response and time course effects of N,N-dimethyltryptamine on disruption of rat shuttle box avoidance. Biol Psychiatr 12 (1977), 339–346.
83. Carbonaro, T.M., Gatch, M.B., Neuropharmacology of N,N-dimethyltryptamine. Brain Res Bull 126 (2016), 74–88.
84. Lowe, L.M., Peterson, B.L., Couper, F.J., A case review of the first analytically confirmed 25I-NBOMe-related death in Washington State. J Anal Toxicol 39 (2015), 668–671.
85. Hill, S.L., Doris, T., Gurung, S., et al. Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series. Clin Toxicol 51 (2013), 487–492.
86. Strassman, R.J., DMT: the Spirit Molecule. A Doctor's Revolutionary Research into the Biology of Near-death and Mystical Experiences. 2001, Park Street Press, Rochester.